Immune%20Dysregulation
Showing 1 - 25 of >10,000
Immune Dysregulation in Patients With COVID-19
Recruiting
- COVID-19
- Immunosuppression
- mid covid-19 patients
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jan 6, 2023
Allergy and Immunology Natural History Study
Recruiting
- Immune Deficiency
- +2 more
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Oct 14, 2022
Long COVID-19, Long COVID Trial (Paxlovid 25 day dosing, Paxlovid 15 day dosing, Control)
Not yet recruiting
- Long COVID-19
- Long COVID
- Paxlovid 25 day dosing
- +2 more
- (no location specified)
Jul 25, 2023
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Immunosuppression Only Conditioning
- +3 more
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS
Recruiting
- Immunodeficiencies
- Immune Dysregulation Syndromes
- Apha/beta T and CD19+ cell depletion using CliniMACS device
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 8, 2022
Myalgic Encephalomyelitis, Chronic Fatigue Syndrome Trial in Torrance, Ithaca, New York (Two-day cardiopulmonary exercise test)
Active, not recruiting
- Myalgic Encephalomyelitis
- Chronic Fatigue Syndrome
- Two-day cardiopulmonary exercise test
-
Torrance, California
- +2 more
Jun 28, 2022
Lymphadenitis, Tuberculous, Immune Defect Trial in Surabaya (Immuno-histochemical staining)
Completed
- Lymphadenitis, Tuberculous
- Immune Defect
- Immuno-histochemical staining
-
Surabaya, East Java, IndonesiaVincentius A Paulo Surabaya Hospital
Jan 8, 2022
Preterm Birth, Inflammation, Stress Trial in New York (Cognitive Challenge)
Recruiting
- Preterm Birth
- +3 more
- Cognitive Challenge
-
New York, New YorkColumbia University Irving Medical Center
Apr 26, 2022
Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy Trial in United States (High-dose methylprednisolone,
Recruiting
- Acute Liver Failure
- +4 more
- High-dose methylprednisolone
- +6 more
-
Los Angeles, California
- +19 more
Dec 5, 2022
Eczema, MTOROC1 Signaling Trial run by the NIAID (L-glutamine)
Withdrawn
- Eczema
- MTOROC1 Signaling
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 13, 2020
Neurotropism and Neuroinflammation in COVID-19 Delirium.
Recruiting
- Covid19
- +2 more
- serology testing profiles description
- +4 more
-
Toulouse, France
- +1 more
Sep 3, 2021
Non Infectious Presentation of Inborn Errors Of Immunity
Not yet recruiting
- Inborn Errors of Immunity
-
Sohag, EgyptSohag University Hospital
May 21, 2023
Down Syndrome, Alopecia Areata, Atopic Dermatitis / Eczema Trial in Aurora (Tofacitinib)
Recruiting
- Down Syndrome
- +5 more
-
Aurora, ColoradoLinda Crnic Institute for Down Syndrome
Jan 17, 2023
Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect Trial in San Francisco
Terminated
- Myeloid Malignancy
- +5 more
- Alemtuzumab
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 25, 2020
End Stage Renal Disease on Dialysis Trial in New Taipei City (Therapeutic diet)
Completed
- End Stage Renal Disease on Dialysis
- Therapeutic diet
-
New Taipei City, TaiwanFar Eastern Memorial Hospital
Mar 15, 2022
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Recruiting
- Benign Lymphoproliferative Disorder
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Sepsis, Acute Respiratory Distress Syndrome, Infections - Pathogen Unspecified Trial in Zagreb (Hemoperfusion)
Recruiting
- Sepsis
- +6 more
- Hemoperfusion
-
Zagreb, Grad Zagreb, CroatiaUniversity Hospital Center Zagreb
Oct 31, 2022
The Alberta BLOOM Long Term Follow Up Study
Terminated
- Infant, Premature, Diseases
- +5 more
-
Calgary, Alberta, CanadaUniversity of Calgary
Mar 29, 2022
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Busulfan test dose
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Unknown or Incompletely Characterized Immune Defects
Recruiting
- Immunodeficiency
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 20, 2022
NIAID Clinical Center Genomics Opportunity Protocol
Completed
- Immune Disorders
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 12, 2023
Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders
Completed
- HIV Infections
- +2 more
-
Baltimore, Maryland
- +1 more
Mar 17, 2023
Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic
Not yet recruiting
- Hepatic Encephalopathy
- +2 more
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research
Jun 13, 2022
Autoinflammatory Diseases Including Juvenile Dermatomyositis
Recruiting
- Autoinflammatory Disease
- Juvenile Dermatomyositis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Precision Diagnostics in Inflammatory Bowel Disease, Cellular
Enrolling by invitation
- Graft Vs Host Disease
- +2 more
-
Boston, Massachusetts
- +1 more
Dec 7, 2022